Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tenth Avenue Leads Investors Introducing Hello Line To Oral Care Market

This article was originally published in The Tan Sheet

Executive Summary

Hello Products changes the oral care aisle, “which looks today a lot like it did 30 years ago,” says Tenth Avenue Holdings principal Joel Citron. Investors also include Harmony Partners and William Morris Endeavor.

You may also be interested in...



Oral Care Brands’ Social Media Fame Is Fuzzy Picture Of Sales Growth

Hello Products is the most popular oral care brand on Instagram and Tom’s of Maine is analyzing how to improve its presence on the burgeoning social media site, but a branding consultant questions whether consumer product firms generate returns on their investment in social media.

Oral Care Brands’ Social Media Fame Is Fuzzy Picture Of Sales Growth

Hello Products is the most popular oral care brand on Instagram and Tom’s of Maine is analyzing how to improve its presence on the burgeoning social media site, but a branding consultant questions whether consumer product firms generate returns on their investment in social media.

Lawsuit Seeking FDA Triclosan Action Stays Alive On Appeal

A court ruling allowing an advocacy group to move forward in its suit against FDA could pave the way for future litigation intended to force the agency to complete delayed regulations.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106312

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel